Ricki Lewis's Blog, page 4

FDA Approves Duvystat, New Oral Treatment for Duchenne Muscular Dystrophy (DMD)

A new drug has entered the arsenal against Duchenne muscular dystrophy (DMD), a genetic disease that affects boys and is challenging to treat. Boys 6 years and older can take Duvystat, to slow the course of the illness. FDA classifies it as a "nonsteroidal treatment" – not a gene therapy, but it affects gene expression.

 

To continue reading, go to DNA Science, where this post first appeared.

How Lume Whole Body Deodorant Was Inspired by a Genetic Disease

Among the barrage of drug ads for cancer, diabetes, weight loss and more are those for Lume, a "doctor-developed whole body deodorant."

 

Lume (pronounced loom-ay) comes as a cream, lotion, stick, wipe, wash, and cleansing bar, to be smeared, rubbed, or wiped anywhere on the human epidermis. Invented to obliterate the distinctive odor of a human female's private parts, Lume has since broadened into a "whole body deodorant." For everyone.

 

Whatever the formulation, Lume lowers the skin's pH (making it more acidic), which kills the bacteria behind the stink. The products infiltrate the many folds and crevices of a vast human skinscape.

 

A Compelling Need

 

I was delighted to discover that the inspiration for Lume is a rare, recessive genetic disease, trimethylaminuria (TMAU), aka "fish odor syndrome."

 

To continue reading, go to DNA Science, where this post was first published. 

Mutations in Three Genes Protect Against Alzheimer’s

Clues to combatting a devastating disease can come from identifying people who have gene variants – mutations – that protect them, by slowing the illness or lowering the risk that it develops in the first place. Understanding how they do this may inspire treatment strategies for the wider patient population.

 

Rare variants of three well-studied genes appear to delay inherited forms of Alzheimer's disease – by decades.

 

Gene #1: The Famous Case of Aliria from the Colombian Family

In 2019. researchers reported on a patient, Aliria Rosa Piedrahita de Villegas, who seemed to have fended off early-onset familial Alzheimer's thanks to a variant of a second, apparently protective gene. The report appeared in Nature Medicine.

Is Identifying Extra X and Y Chromosomes a Good Idea, or Does it Invite Stigma?

Sequencing our genomes is a 21rst century phenomenon. Discrimination based on genetics dates back to the start of the eugenics movement in the 1880s. Will an effort to determine the sex chromosome constitutions of nearly 600,000 men whose DNA is being analyzed in the Million Veteran Program provide helpful health information – or highlight another possible source of genetic judgment?

 

Researchers at the University of Colorado Anschutz Medical Campus and collaborators across the US report the largest and most diverse study of men with extra X or Y chromosomes in the US. Their findings appear in the March 29, 2024 JAMA Network Open. The Million Veteran Program is a national effort considering how genes, lifestyle, military experiences, and environmental exposures affect health and wellness among veterans. It launched in 2011.

 

The Biology of Sex Chromosomes

“Ordinary Soil” Revisits the Weedkiller and AgBiotech Story, While Feeding the Scientist-As-Nerd Stereotype

I love the spectacular symbiosis of my vegetable garden as harvest time approaches.

 

Beanstalks spiral up cornstalks, their tendrils teasing nearby tomato stems. Below, broad leaves protect ballooning squashes from the slugs that appear, seemingly from nowhere, after a rain, while providing water for passing furry creatures.

 

The synergism of a garden is an ancient and somewhat obvious idea. Many indigenous peoples honored the "three sisters" of corn, beans, and squash. My kids – three sisters – learned about the practice in grade school, and all recall the first meal that we grew: corn, beans, and squash.

 

Those memories returned as I read Alex Woodard's excellent novel Ordinary Soil.

 

To continue reading, go to DNA Science, where this post first appeared.

How the Human Lost Its Tail

In 1902's Just So Stories for Little Children, British author Rudyard Kipling famously explained curiosities of the animal kingdom: How the Leopard Got His Spots, How the Camel got his Hump, How the Rhinoceros got his Skin, to name a few.

 

Reading Just So Stories was one of my earliest memories of thinking like a scientist. I see them in articles on animals' oddities, such as How the Tabby Got its Stripes, in which I explored a molecular explanation for fur color patterns set in the fetus, from a report in Nature Communications.

 

Now new research published in Nature brings the just-so approach to the loss of tails among apes – including us.

 

Apes R Us

 

Whether or not taillessness was a liability as we evolved depends upon perspective and imagination. Would absence of a fifth appendage have made walking erect – bipedalism – easier? All mammals other than apes have tails, if only as embryos, which is the case for humans. Our tailbones are the remnants of tails.

 

To continue reading, go to DNA Science, where this post first appeared.

Cultivated Meat? Let Them Eat Snake

Biotechnology has solved many problems, from recombinant DNA and monoclonal antibody-derived drugs, to gene therapy and stem cell transplants, to RNA-based vaccines and genetically modified plants that resist diseases and pesticides.

 

In contrast, so-called cultivated meat has been, so far, a failure.

 

Joe Fassler's in-depth Opinion piece in the February 9 New York Times, The Revolution That Died on Its Way to Dinner, digests the unrealistic expectations, shortcuts, and glitches that have stymied what he envisions as "a high-tech factory housing steel tanks as tall as apartment buildings and conveyor belts rolling out fully formed steaks, millions of pounds a day — enough, astonishingly, to feed an entire nation."

 

Making Meat

 

To continue reading, go to DNA Science, where this post was first published. 

Older Siblings Made Possible Just-Approved Gene Therapy for Metachromatic Leukodystrophy

The Food and Drug Administration just announced approval of Lenmeldy (atidarsagene autotemcel), a gene therapy to treat the neurological condition metachromatic leukodystrophy (MLD). Available in Italy for three years, Lenmeldy (atidarsagene autotemcel), from Orchard Therapeutics, is groundbreaking, but comes at quite a cost – the $4.25 million price tag for the one-time infusion, and for the older siblings who contributed to developing the gene treatment, but were too sick to receive it.

 

An Ultrarare Neurological Condition

 

MLD affects the white matter in the brain, causing progressive loss of mobility and sensation, as well as intellectual decline and, ultimately, unresponsiveness.

 

To continue reading, go to DNA Science, where this post first appeared.

Chewing Gum Reveals Stone Age Diet and Disease

 

We can learn about life, past and present, anywhere we find DNA and determine its sequence. DNA Science has described intriguing sources of environmental DNA, aka eDNA: DNA in Strange Places: Hippo Poop, Zoo Air, and Cave Dirt and A Glimpse of the Ocean's Twilight Zone Through Environmental DNA.  

 

Human remains also harbor bits of DNA that can reveal how people lived long ago.

 

A recent report in PLOS ONE analyzes DNA from an adenovirus and a herpes virus discovered in preserved feces – coprolites – from 5,500 to 7,000 years ago at an archaeological site in Japan. The findings suggest that those people might have suffered from similar infections to humans today.

 

A second recent report uncovers clues in preserved chewing gum, reminding me of Flintstones gummy vitamins. (See A Brief History of Flintstones Vitamins). 

 

About 9,700 years ago, a group of teens were hunting, gathering, and fishing along the western coast of Scandinavia, north of what is today Göteborg. They chewed a concoction of hardened birch tar, the preserved lumps bearing bitemarks that suggest the stuff was used as a chewing gum of sorts, perhaps also as an adhesive in construction. An international research team published their findings on the Mesolithic gum in Scientific Reports.

 

To continue reading, go to DNA Science, where this post first appeared. 

Transmissible Alzheimer’s Disease? Long-Ago Growth Hormone Treatment and a Legacy of Cannibalism and Mad Cows

Five people treated for pituitary dwarfism decades ago with human growth hormone (hGH) pooled from cadavers have shown cognitive decline reminiscent of early-onset Alzheimer's disease. Their dementia likely arose from transmission of the bits of amyloid-beta protein that lie behind Alzheimer's delivered along with the needed hormone, initiating a molecular chain reaction that led to brain effects decades later. Recombinant DNA technology has since provided a pure source of the hormone.

 

The cognition decline in these people is iatrogenic – caused by a medical procedure. The pooled hGH included infectious proteins, called prions (pronounced "pree-ons"), short for "proteinaceous infectious agent." The research appears in Nature Medicine from long-time prion researcher John Collinge, director of the University College London Institute of Prion Diseases, and colleagues.

 

The team followed 8 patients. Two of the five with clinical signs of Alzheimer's died during the investigation, and autopsy revealed the telltale brain changes. Two other patients had mild cognitive impairment, and the eighth had no symptoms. None had mutations that cause Alzheimer's disease, ruling out genetics as a cause.

 

To continue reading, go to DNA Science, where this post first appeared.